L Capital Partners Mergers and Acquisitions Summary

Private Equity Profile

L Capital Partners’ most common sectors for investment are life science (25%) and medical products (25%). The Firm’s most common investment types include venture (88%) and growth capital (7%). In total, L Capital Partners has invested in 10 US states and 2 different countries. Its largest (disclosed) acquisition occurred in 2007 when it acquired Locus Pharmaceuticals for $30M.

The Firm’s most common exit type is trade sale (72%). L Capital Partners’ largest (disclosed) exit occurred in 2008 when it sold Protez Pharmaceuticals for $400M.

Join Mergr to view L Capital Partners’ full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity23
    • M&A Buy Activity16
    • M&A Sell Activity7
  • Total Sectors Invested 10
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 12
  • M&A Advisors 1

L Capital Partners

10 East 53rd Street, 37th Floor,
New York, New York 10022
United States
(212) 675-7755
www.lcapitalpartners.com
info@lcapitalpartners.com

L Capital Partners is a specialist private equity firm focused on investing in companies operating within the healthcare, technology, and energy/environmental sectors, looking to bring 'groundbreaking products to market'. Within healthcare, L Capital looks to invest in biopharmaceutical and medical device businesses. Within technology, the Firm's emphasis is on security/defense and IT businesses. And within the energy/environmental sector, the L Capital's focus is investing in opportunities that 'improve the quality of life'. L Capital was formed in 2004 and has offices in New York City and Tel Aviv, Israel.


Investment Criteria

Sectors of Interest: Aerospace, Communications, Defense, Electronics, Energy Services and Equipment, Environmental, Healthcare Services, Information Technology, Life Science, Medical Products, Oil/Gas Exploration, Renewable Energy, Semiconductors, Technology Hardware

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Stake Purchase, Venture

Geographic Preferences: East US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.0/yr) # 16 - - - - - 16
vol $58M $58M
Sell (0.0/yr) # 7 - - - - - 7
vol $445M $445M
  23

Most Recent M&A

Company Date Value Type
WiSpry, Inc. 2015-05-11 - Add-on Acquisition
Irvine, California · www.wispry.com
Vicini SpA 2014-04-07 - Growth Capital
San Mauro Pascoli, · www.vicinishoes.com
iScience Interventional, Inc. 2014-01-06 - Add-on Acquisition
Menlo Park, California · www.iscienceinterventional.com
OnPATH Technologies, Inc. 2012-11-01 40M USD Add-on Acquisition
Marlton, New Jersey · www.onpathtech.com
Eleme Medical, Inc. 2011-02-03 5M USD Add-on Acquisition
Merrimack, New Hampshire · www.smoothshapes.com
Tengion, Inc. 2010-04-09 - IPO
Winston-Salem, North Carolina · www.tengion.com
iScience Interventional, Inc. 2009-05-01 21M USD Venture
Menlo Park, California · www.iscienceinterventional.com
WiSpry, Inc. 2009-03-01 - Venture
Irvine, California · www.wispry.com
Evogen, Inc. 2008-12-12 3M USD Venture
Kansas City, Missouri · www.evogen.com
CeNeRx BioPharma, Inc. 2008-10-17 - Venture
Cary, North Carolina · www.cenerx.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 1 (17%) 30M (81%) 4 (25%) 30M (52%)
Medical Products - - 4 (25%) 21M (36%)
Information Technology 1 (17%) 4M (11%) 1 (6%) 4M (7%)
Technology Hardware 1 (17%) 3M (8%) 1 (6%) 3M (5%)
Aerospace - - 1 (6%) -
Communications - - 1 (6%) -
Consumer Products 1 (17%) - 1 (6%) -
Electronics 1 (17%) - 1 (6%) -
Environmental 1 (17%) - 1 (6%) -
Semiconductors - - 1 (6%) -
Total 6 $37M 16 $58M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 5 (100%) 37M (100%) 15 (100%) 58M (100%)
  California - - 3 (20%) 21M (36%)
  Pennsylvania 1 (20%) 30M (81%) 2 (13%) 30M (52%)
  New York 1 (20%) 4M (11%) 2 (13%) 4M (7%)
  North Carolina - - 2 (13%) -
  Missouri 1 (20%) 3M (8%) 1 (7%) 3M (5%)
  Wisconsin 1 (20%) - 1 (7%) -
  Maryland 1 (20%) - 1 (7%) -
  Virginia - - 1 (7%) -
  New Jersey - - 1 (7%) -
  New Hampshire - - 1 (7%) -
Total 5 $37M 15 $58M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 5 (83%) 37M (100%) 14 (88%) 58M (100%)
Growth Capital 1 (17%) - 1 (6%) -
Stake Purchase - - 1 (6%) -
Total 6 $37M 16 $58M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 5 (71%) 445M (100%)
Bankruptcy 1 (14%) -
IPO 1 (14%) -
Total 7 $445M

Top M&A Advisors

Financial Deals
DVR Capital
1

Deal Values

buy # Total
< $100M 4 $58M
TOTAL $58M
Largest Locus Pharmaceuticals, Inc.
$30M (2007-02-13)
sell # Total
$100M to $1B 1 $400M
< $100M 2 $45M
TOTAL $445M
Largest Protez Pharmaceuticals, Inc.
$400M (2008-06-04)

M&A Connections

Deals
Exited to
Strategic(s)
71%
5 (71%)

 Subscribe to unlock this and 167,278
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 156K M&A Transactions
  • 163K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.3K M&A Advisors
    (Investment Banks and Law Firms)
  • 55K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.